News

The US Food and Drug Administration (FDA) has approved Gilead Sciences' injectable product, Yeztugo (lenacapavir), as a ...
GILD wins FDA approval for Yeztugo, the first and only twice-yearly injectable PrEP for HIV prevention in the United States.
Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent ...
The Food and Drug Administration has approved a highly effective new HIV prevention medication, known as Yeztugo. In clinical ...
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
Gilead has plans for a rapid launch in the United States as well as a wider rollout of the drug in collaboration with global ...
FDA approves Gilead Sciences' groundbreaking HIV prevention injection, Yeztugo, with 99.9% effectiveness, but high cost ...
In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.
It's unclear how many people in the US and abroad will get access to the powerful new HIV prevention medication ...
In Shelby County, which is one of the largest HIV transmission areas in the country according to a 2024 study, people looking ...